Description
Empagliflozin is a medication used to treat patients with type 2 diabetes mellitus. It is typically administered as a tablet taken once a day, with or without food. These tablets inhibit the enzyme sodium-glucose cotransporter-2, which ultimately reduces blood sugar levels within the body. Alongside its glucose-inhibiting properties, empagliflozin also promotes weight loss and prevents cardiovascular disease.
Ingredients
Drug Class
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor
Uses
Unveiling its multifaceted uses and transformative applications as follows:
- Controls diabetes mellitus type 2
- Helps reduce risk of stroke
- Reduce accumulation of sodium (salt) in the body
- Reduce swelling (edema) in legs
- Manage fluid around heart
- Slow down progressive kidney disease
- Help lose weight
- Control high blood pressure
Reviews
There are no reviews yet.